Search

Search Constraints

You searched for: Author/Creator Doecke, James D

Search Results

1. Alzheimer's disease specific MRI brain regions are differentially associated with accelerated decline as defined using sigmoidal cognitive turning point methodology in amyloid‐positive AIBL participants. (20th December 2022)

2. AlzoSure® Predict, a simple minimally‐invasive blood test to predict the early onset of Alzheimer's disease before the manifestation of clinical symptoms. (20th December 2022)

3. Cerebrospinal fluid biomarker levels are not affected by aspiration or gravity drip extraction methods in Alzheimer's disease: The AIBL study: Biomarkers (non‐neuroimaging): Method development and validation. (7th December 2020)

4. Comparing the longitudinal progression of CSF biomarkers with PET Amyloid biomarkers for Alzheimer's disease. (20th December 2022)

6. Identification of genetic markers linked to accelerated brain volume changes in Aβ‐positive population: Biomarkers (non‐neuroimaging): Longitudinal and prognostic biomarker studies. (7th December 2020)

7. Leukocyte Surface Biomarkers Implicate Deficits of Innate Immunity in Late‐onset Alzheimer's Disease. (20th December 2022)

8. Longitudinal evaluation of the natural history of amyloid-β in plasma and brain. Issue 1 (14th April 2020)

9. Plasma pTau181/Aβ42 identifies cognitive change earlier than CSF pTau181/Ab42. (20th December 2022)